Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5467]
News [12732]
Articles [180]
Editorials [5]
Conferences [249]
elearning [17]
Nab-paclitaxel and gemcitabine combating pancreatic cancer
Dr Michel Ducreux – Institut Gustave Roussy, Paris, France
Nab-paclitaxel and gemcitabine combating pancreatic cancer ( Dr Michel Ducreux – Institut Gustave Roussy, Paris, France )
12 Oct 2012
Hepatic chemosaturation therapy
Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute...
Hepatic chemosaturation therapy ( Dr Krishna Kandarpa – Delcath Systems Inc, Dr Pier Ferrucci – European Insitute of Oncology, Milan, Italy )
11 Oct 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012
Surgical challenges to retroperitoneal sarcomas
Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy
Surgical challenges to retroperitoneal sarcomas ( Dr Angelo Dei Tos – Department of Oncology, General Hospital of Treviso, Italy )
9 Oct 2012
Clinical trials and drug developments in pancreatic cancer
Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy
Clinical trials and drug developments in pancreatic cancer ( Dr Roberto Labianca – Ospedali Riuniti Bergamo, Italy )
9 Oct 2012
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast...
Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy
The Neo ALTO Study, combination therapy of lapatinib and trastuzumab and breast conservation surgery ( Dr Carmen Criscitiello - European Institute of Oncology, Milan, Italy )
9 Oct 2012
MET inhibitors for non-small cell lung cancer
Prof Georgio Scagliotti – University of Torino, Italy
MET inhibitors for non-small cell lung cancer ( Prof Georgio Scagliotti – University of Torino, Italy )
9 Oct 2012
Treatment of ALK+ lung cancer with crizotinib, Profile 1007
Dr Alice Shaw – Massachusetts General Hospital, Boston, USA
Treatment of ALK+ lung cancer with crizotinib, Profile 1007 ( Dr Alice Shaw – Massachusetts General Hospital, Boston, USA )
8 Oct 2012
The first phase II trial for the management of oesophageal cancer
Prof David Ferry – New Cross Hospital, Wolverhampton, UK
The first phase II trial for the management of oesophageal cancer ( Prof David Ferry – New Cross Hospital, Wolverhampton, UK )
8 Oct 2012
Phase III MISSION trial: Sorafenib does not extend overall survival as third or...
Dr Tony Mok – The Chinese University of Hong Kong
Phase III MISSION trial: Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer ( Dr Tony Mok – The Chinese University of Hong Kong )
8 Oct 2012
Personalised cancer medicine and research: Today’s best practice
Prof José Baselga - Massachusetts General Hospital, Boston, USA
Personalised cancer medicine and research: Today’s best practice ( Prof José Baselga - Massachusetts General Hospital, Boston, USA )
5 Oct 2012
Treating liver metastases in colorectal cancer
Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany
Treating liver metastases in colorectal cancer ( Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany )
4 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation